ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012

Computer Sciences Corp. Wins NIH Information System Contract

September 20, 2002

OMB Backs Down, Releases New Construction Funds After Ruling They Are “Alteration, Renovation”

December 13, 1974

Some Tumors Show Partial Response To Drug Combo

January 27, 2006

RFAs available: Chemoprevention Clinical Trials

July 22, 1994

Trials Approved by NCI CTEP For the Month of January

January 27, 2012